Test Code ALBFL Albumin, Body Fluid
Ordering Guidance
For cerebrospinal fluid (CSF) specimens, order ALBSF / Albumin, Spinal Fluid. Testing will be changed to ALBSF if this test is ordered on that specimen type.
Necessary Information
1. Date and time of collection are required.
2. Specimen source is required.
Specimen Required
Specimen Type: Body fluid
Preferred Source:
-Peritoneal fluid (peritoneal, abdominal, ascites, paracentesis)
-Pleural fluid (pleural, chest, thoracentesis)
-Drain fluid (drainage, JP drain)
Acceptable Source: Write in source name with source location (if appropriate)
Collection Container/Tube: Sterile container
Submission Container/Tube: Plastic vial
Specimen Volume: 1 mL
Collection Instructions:
1. Centrifuge to remove any cellular material and transfer into a plastic vial.
2. Indicate the specimen source and source location on label.
Useful For
Aiding in identifying the cause of ascites
Aiding in differentiating exudative and transudative pleural effusions
Method Name
Colorimetric
Reporting Name
Albumin, BFSpecimen Type
Body FluidSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Body Fluid | Refrigerated (preferred) | 7 days | |
Frozen | 30 days | ||
Ambient | 24 hours |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross Icterus | Reject |
Anticoagulant or additive Breast milk Nasal secretions Gastric secretions Bronchoalveolar lavage (BAL) or bronchial washings Colostomy/ostomy Feces Urine Saliva Sputum Vitreous fluid |
Reject |
Clinical Information
Peritoneal fluid:
Ascites is the pathologic accumulation of excess fluid in the peritoneal cavity caused by changes in vascular permeability, hydrostatic pressure, and oncotic pressure. The most common causes of ascites in individuals are cirrhosis (80%), malignancy (10%), cardiac failure (5%), and infection.
Total protein results of 3.0 g/dL or greater, historically used to classify ascites fluid as transudate or exudate, has a reported accuracy of only 55% in identifying exudates and has been largely replaced with measurement of the serum-ascites albumin gradient (SAAG), calculated as serum albumin concentration minus ascites albumin concentration.
SAAG has been shown to correlate directly with portal pressure and SAAG results of 1.1 g/dL or greater are 97% accurate at identifying portal hypertension. Conditions associated with high SAAG include cirrhosis, acute liver failure, fatty liver disease, alcoholic hepatitis, portal vein thrombosis, hepatic malignancy, and veno-occlusive disease. Cardiac ascitic fluid caused by congestive heart failure has both a high SAAG result (≥1.1 g/dL) and total protein concentration greater than 2.5 g/dL. Conditions associated with low SAAG measurement (<1.1 g/dL) include peritoneal malignancy, tuberculosis, pancreatitis, connective tissue disease, and nephrotic syndrome.
Pleural fluid:
Pleural fluid is normally present within the pleural cavity surrounding the lungs, serving as a lubricant between the lungs and inner chest wall. Pleural effusion develops when the pleural cavity experiences an overproduction of fluid due to increased capillary hydrostatic and osmotic pressure that exceeds the ability of the lymphatic or venous system to return the fluid to circulation. Laboratory-based criteria are often used to classify pleural effusions as either exudative or transudative. Exudative effusions form due to infection or inflammation of the capillary membranes allowing excess fluid into the pleural cavity. Patients with these conditions benefit from further investigation and treatment of the local cause of inflammation. Transudative effusions form due to systemic conditions such as volume overload, end-stage renal disease, and heart failure that can lead to excess fluid accumulation in the pleural cavity. Patients with transudative effusions benefit from treatment of the underlying condition.(1) Dr. Richard Light derived criteria in the 1970s for patients with pleural effusions that are still used today.(2) Dr. Light's criteria were designed to be sensitive for detecting exudates at the expense of specificity.(3) Heart failure and recent diuretic use contribute to most misclassifications by Dr. Light's criteria (transudates falsely categorized as exudates). Serum-to-fluid protein or albumin gradient (serum protein or albumin minus fluid protein or albumin) may be calculated in these cases and when more than 3.1 g/dL (protein) or 1.2 g/dL (albumin) suggests the patient has a transudative effusion.
Reference Values
An interpretive report will be provided
Interpretation
Peritoneal fluid albumin is used to calculate the serum-ascites albumin gradient. Values of 1.1 g/dL or higher suggest portal hypertension.
Pleural fluid albumin may be used to calculate a serum-effusion albumin gradient. Values above 1.2 g/dL are most consistent with a transudative process.
For all other fluids, the albumin concentration and gradient have only been evaluated in peritoneal and pleural fluids. All other fluid albumin concentrations should be interpreted in conjunction with serum albumin concentration and other clinical findings.
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 2 daysSpecimen Retention Time
1 weekPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82042
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ALBFL | Albumin, BF | 1747-5 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
ALBF | Albumin BF | 1747-5 |
797FL | Fluid Type, Albumin | 14725-6 |